MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

F Fazekas, JB Chawluk, A Alavi… - American journal of …, 1987 - Am Roentgen Ray Soc
The type, frequency, and extent of MR signal abnormalities in Alzheimer's disease and normal
aging are a subject of controversy. With a 1.5-MR unit we studied 12 Alzheimer patients, …

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

…, GJ Biessels, C Cordonnier, F Fazekas… - The Lancet …, 2013 - thelancet.com
Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …

Quantitative MR imaging of brain iron: a postmortem validation study

…, W Goessler, E Scheurer, F Ebner, K Yen, F Fazekas… - Radiology, 2010 - pubs.rsna.org
Purpose To investigate the relationship between transverse relaxation rates R2 and R2*, the
most frequently used surrogate markers for iron in brain tissue, and chemically determined …

Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of …

F Fazekas, R Kleinert, G Roob… - American journal …, 1999 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Patients with spontaneous intracerebral hemorrhage (ICH)
frequently have small areas of signal loss on gradient-echo T2*-weighted MR images, …

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis

F Fazekas, F Deisenhammer, S Strasser-Fuchs… - The Lancet, 1997 - thelancet.com
Background Multiple sclerosis is an autoimmune disorder characterised by the repeated
occurrence of demyelinating lesions within the central nervous system. Uncontrolled studies …

[HTML][HTML] MRI-guided thrombolysis for stroke with unknown time of onset

…, B Cheripelli, TH Cho, F Fazekas… - … England Journal of …, 2018 - Mass Medical Soc
Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke
only if it can be ascertained that the time since the onset of symptoms was less than 4.5 …

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

…, N de Stefano, C Enzinger, F Fazekas… - The Lancet …, 2021 - thelancet.com
The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple
Sclerosis Centres guidelines on the use of MRI in diagnosis and monitoring of multiple …

Pathologic correlates of incidental MRI white matter signal hyperintensities

F Fazekas, R Kleinert, H Offenbacher, R Schmidt… - Neurology, 1993 - AAN Enterprises
We related the histopathologic changes associated with incidental white matter signal
hyperintensities on MRIs from 11 elderly patients (age range, 52 to 82 years) to a descriptive …

White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors.

F Fazekas, K Niederkorn, R Schmidt, H Offenbacher… - Stroke, 1988 - Am Heart Assoc
We studied 52 asymptomatic subjects using magnetic resonance imaging, and we compared
age-matched groups (51-70 years old) with and without white matter lesions with respect to …

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

…, T Coetzee, G Comi, J Correale, F Fazekas… - The Lancet …, 2018 - thelancet.com
The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research
and clinical practice. Scientific advances in the past 7 years suggest that they might no …